Evidence map›Paper›PMID 25978333›Full record

ArticlePloS one2015

Silica Triggers Inflammation and Ectopic Lymphoid Neogenesis in the Lungs in Parallel with Accelerated Onset of Systemic Autoimmunity and Glomerulonephritis in the Lupus-Prone NZBWF1 Mouse.

Melissa A Bates, Christina Brandenberger, Ingeborg Langohr, Kazuyoshi Kumagai, Jack R Harkema, Andrij Holian, James J Pestka

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Journal of biomedical research · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Systemic Lupus Erythematosus Risk: The Role of Environmental Factors.Rheumatic diseases clinics of North America · 2022
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Melissa A BatesDepartment of Food Science and Human Nutrition, Michigan State University, East Lansing, Michigan, United States of America; Center for Integrative Toxicology, Michigan State University, East Lansing, Michigan, United States of America.
Christina BrandenbergerDepartment of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, Michigan, United States of America; Functional and Applied Anatomy, Hannover Medical School, Hannover, Germany.
Ingeborg LangohrDepartment of Pathobiological Studies, School of Veterinary Medicine, Louisiana State University, Baton Rogue, Louisiana, United States of America.
Kazuyoshi KumagaiCenter for Integrative Toxicology, Michigan State University, East Lansing, Michigan, United States of America; Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, Michigan, United States of America.
Jack R HarkemaCenter for Integrative Toxicology, Michigan State University, East Lansing, Michigan, United States of America; Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, Michigan, United States of America.
Andrij HolianCenter for Environmental Health Sciences, University of Montana, Missoula, Montana, United States of America.
James J PestkaDepartment of Food Science and Human Nutrition, Michigan State University, East Lansing, Michigan, United States of America; Center for Integrative Toxicology, Michigan State University, East Lansing, Michigan, United States of America.
Michigan United · USMichigan State University · USCenter for Environmental Health · USLouisiana State University · US

Funding

Dietary Lipids and Silica-Accelerated AutoimmunityR21ES021265 · NIEHS · MICHIGAN STATE UNIVERSITY · PI PESTKA, JAMES J · 2012 to 2013
$381k
NIEHS NIH HHS ES021265NIEHS NIH HHS R21 ES021265
6 · The paper itself

Abstract

Genetic predisposition and environmental factors influence the development of human autoimmune disease. Occupational exposure to crystalline silica (cSiO2) has been etiologically linked to increased incidence of autoimmunity, including systemic lupus erythematosus (SLE), but the underlying mechanisms are poorly understood. The purpose of this study was to test the hypothesis that early repeated short-term cSiO2 exposure will modulate both latency and severity of autoimmunity in the lupus-prone female NZBWF1 mouse. Weekly intranasal exposure to cSiO2 (0.25 and 1.0 mg) for 4 wk beginning at 9 wk of age both reduced latency and increased intensity of glomerulonephritis. cSiO2 elicited robust inflammatory responses in the lungs as evidenced by extensive perivascular and peribronchial lymphoplasmacytic infiltration consisting of IgG-producing plasma cells, and CD45R+ and CD3+ lymphocytes that were highly suggestive of ectopic lymphoid tissue (ELT). In addition, there were elevated concentrations of immunoglobulins and the cytokines MCP-1, TNF-α and IL-6 in bronchoalveolar lavage fluid. cSiO2-associated kidney and lung effects paralleled dose-dependent elevations of autoantibodies and proinflammatory cytokines in plasma. Taken together, cSiO2-induced pulmonary inflammation and ectopic lymphoid neogenesis in the NZBWF1 mouse corresponded closely to systemic inflammatory and autoimmune responses as well as the early initiation of pathological outcomes in the kidney. These findings suggest that following airway exposure to crystalline silica, in mice genetically prone to SLE, the lung serves as a platform for triggering systemic autoimmunity and glomerulonephritis.

Indexed as

AnimalsAutoimmunityBronchoalveolar Lavage FluidChemokine CCL2FemaleGlomerulonephritisInflammationInterleukin-6LungLupus Erythematosus, SystemicMaleMiceSilicon DioxideTumor Necrosis Factor-alphaChemokine CCL2Interleukin-6Silicon DioxideTumor Necrosis Factor-alpha

Identifiers

PMID25978333
PMCPMC4433215
OpenAlexW1552501994

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.